![Ulrich G. Traugott](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ulrich G. Traugott
Geen lopende functies
Profiel
Ulrich G.
Traugott worked as a Director of Medicine at Atugen AG, Medical Director at Glaxo Wellcome, Director of Medical Oncology at Knoll Pharmaceutical Co., and Manager of Clinical Research at Genentech, Inc. He holds a graduate and doctorate degree from Ruprecht-Karls-Universität Heidelberg.
Eerdere bekende functies van Ulrich G. Traugott
Bedrijven | Functie | Einde |
---|---|---|
Knoll Pharmaceutical Co. | Corporate Officer/Principal | - |
Glaxo Wellcome, Inc. | Hoofd Techniek/Wetenschap/O&O | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Ulrich G. Traugott
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
Glaxo Wellcome, Inc. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Knoll Pharmaceutical Co. |